A cautionary tale.
Type 2 diabetes is increasing in prevalence and is predominantly managed in general practice. This series contains case histories raising some of the metabolic problems which may be encountered in the management of these patients and indicates some of the many issues, other than glycaemic control, that need to be considered.
Tallis
G A
GA
Flinders Medical Centre, Bedford, South Australia.
Phillips
P J
PJ
Popplewell
P Y
PY
D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D002121:Calcium Channel Blockers / Q000009:adverse effects; D002752:Chlorthalidone / Q000009:adverse effects; D000075202:Contraindications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D006333:Heart Failure / Q000209:etiology*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D008297:Male; D009543:Nifedipine / Q000009:adverse effects
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D009543:Nifedipine; D002752:Chlorthalidone